An Accurate Diagnostic & Monitoring Solution
Our diagnostic can achieve the specificity and sensitivity required for the detection of pancreatic cancer at an earlier stage, and allowing for more options for successful treatment. As a monitoring tool, our assay can track the progress or the regression of the disease and be a valuable aid to the clinician for assessing the appropriate form of treatment for each patient.

Detection tools to diagnose pancreatic cancer at early stages is an urgent unmet medical need.
>90%
Pancreatic ductal adenocarcinoma (PDAC) accounts for greater than 90% of all pancreatic cancer cases and is notoriously difficult to detect at early stages
A lack of early diagnostics leads to scarce effective treatment options and a substantially greater risk of death
>50%
More than half of patients are suffering from advanced disease at the time of diagnosis